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How innate immune response causes autoimmunity has remained an enigma. In this issue of Cell Host &
Microbe, Mattner et al. demonstrate that invariant natural killer T cells activated by the mucosal commensal
Novosphingobium aromaticivorans precipitate chronic T cell-mediated autoimmunity against small bile
ducts that mirrors human primary biliary cirrhosis. These findings provide a mechanistic understanding of
the role of innate immunity toward a microbe in the development of autoimmunity.Autoimmune diseases manifest when
tolerance to self breaks down and the
very same immune system that evolved
to protect us frommicrobes and parasites
turns against our vital tissues. Autoimmu-
nity is determined by genetic predisposi-
tion and environmental triggers, including
microbial infections that might result in
autoimmune attack due to molecular
mimicry between microbial and host
macromolecules. Irrespective of the un-
derlyingmechanism,autoimmunityensues
whenvital tissues are under chronic attack
by effector T and B lymphocytes of the
adaptive immune system. Activation of
the innate immune system precedes elici-
tation of the adaptive immune response.
Cells of the innate immune system recog-
nize pathogen-associated molecular pat-
terns (PAMPs) throughpattern recognition
receptors (PRRs). Among the PRRs, Toll-
like receptors, which recognize microbial
components such as lipopolysaccharides
(LPS), glycolipids, and nucleic acids, have
been studied extensively (Marshak-Roth-
stein and Rifkin, 2007).
Human primary biliary cirrhosis (PBC) is
a lethal autoimmune disease in which
small bile ducts in the liver are under
chronic attack by T and B lymphocytes.
PBC is linked to signature autoantibodies
directed against host mitochondrial pyru-
vate dehydrogenase complex (PDC)-E2,
which is a molecular mimic of a phyloge-
netically relatedmicrobial enzyme (Kaplan
and Gershwin, 2005). One such microbe,
Novosphingobium aromaticivorans, is
a member of the Sphingomonadaceae
family of Gram-negative a-Proteobacteria
(Kaplan and Gershwin, 2005). These bac-
teria are ubiquitous in nature, are harmless
commensals of mucosal surfaces, andreplicate extracellularly inside the host.
The cell wall of N. aromaticivorans
lacks LPS but is instead constituted
of a-anomeric glycosphingolipids (e.g.,
a-galacturonosylceramides [aGalACer])
(Kawahara et al., 2000). In this issue of
Cell Host & Microbe, Mattner et al. (2008)
provide new insight regarding the mecha-
nisms by which a microbe that lacks LPS
activates the innate immune system and
breaks immune tolerance, triggering PBC
in mice.
Invariant natural killer T (iNKT) cells are
found at the splenic marginal zones and
patrol hepatic sinusoids where blood-
borne pathogens enter peripheral lym-
phoid organs. Here, iNKT cells react with
glycolipid antigens such as aGalACer pre-
sented by CD1d molecules and jumpstart
innate and adaptive immune responses.
The unique semi-invariant T cell receptor
of iNKT cells recognizes a-anomeric
head group patterns within microbial gly-
colipids such as aGalACer of Sphingomo-
nas spp. and a-galactosyldiacylglycerols
of Borrelia burgdorferi and hence func-
tions as a PRR. iNKT cells are considered
innate lymphocytes because they are
activated by PAMPs and rapidly secrete
effector cytokines and chemokines that
transactivate other cells of the innate
and adaptive immune systems (Bendelac
et al., 2007).
Immunity to Sphingomonas spp. re-
quires iNKT cells. Curiously, high-dose
Sphingomonas infection caused an iNKT
cell-dependent septic shock, perhaps
due to an explosive cytokine storm, which
slowly waned in mice that recovered from
low-dose infection (Bendelac et al., 2007).
Mattner et al. (2008) show that N. aroma-
ticivorans, akin to its relatives, producesCell Host & MaGalACer, which triggers the initial innate
immune reaction characterized by iNKT
cell activation. Activated iNKT cells
then potentiate T and B lymphocyte re-
sponses, which culminate in the elicitation
of signature antibodies directed against
bacterial PDC-E2 that crossreact with
the homologous mitochondrial enzyme.
Mice immunized with model B (e.g., ov-
albumin) and iNKT (a-galactosylceramide
[aGalCer], a close mimic of aGalACer) cell
antigens showed that iNKT cells can
help B cells in antigen-specific antibody
responses (Van Kaer, 2005). Whether this
help entailed direct cognate iNKT-B cell
interactions or indirect, iNKT cell-depen-
dent conventional T-B cell interactions
was an open question. To distinguish be-
tween the twomodels of B cell help, Matt-
ner et al. (2008) generatedmixed radiation
chimeras by transferring Ighb (immuno-
globulin heavy chain allotype b);Cd1d+
and Igha;Cd1d0 bone marrow cells into
lethally irradiated wild-type mice. N.
aromaticivorans infection of such chi-
meras resulted predominantly in IgG2ab
as well as both IgMa and IgMb autoanti-
body response against PDC-E2. These
findings indicated that iNKT cell help in
antibody isotype switching requires cog-
nate iNKT-B cell interaction, which entails
presentation of aGalACer by CD1d mole-
cules on the same B cell that responds to
the microbial enzyme (Figure 1).
Mattner et al. (2008) also demonstrated
thatN. aromaticivorans infection activates
conventional peptide-reactive T cells in an
iNKT cell-dependent manner. Interest-
ingly, however, these conventional T cells
remained activated even after clearance
of the majority of the bacterial organisms
and precipitated disease upon transfericrobe 3, May 2008 ª2008 Elsevier Inc. 275
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mice autonomous of the infectious trigger
and activated iNKT cells. Hence, early
iNKT cell-dependent cytokine storm trig-
gered by initial encounter with N. aromati-
civorans is central to breach of immune
tolerance that causes PBC. These find-
ings establish the missing connection
between the microbial innate immune
trigger and chronic effector T and B
lymphocyte attack of small bile ducts
observed in PBC (Figure 1).
The mechanism by which iNKT cell
activation primes conventional T cells
against autoantigens remains ill-defined.
Numerous studies have shown that iNKT
cells activated by aGalCer transactivate
CD4 and CD8 T cells (Van Kaer, 2005).
Figure 1. Postulated Immune Events that Precipitate Primary Biliary Cirrhosis
(A) Immune events. iNKT cells reside within the liver and spleen at sites where blood-borne microbes enter
these lymphoid organs. Here, dendritic cells (DCs) and B cells present CD1d-restricted glycolipid antigens
such as a-galacturonosylceramide (aGalACer) to iNKT cells. Antigen presentation by these cells can occur
either by direct binding of glycolipids to CD1d at the cell surface or after endolysosomal delivery of micro-
bial glycolipids. Endolysosomal delivery entails either phagocytosis of the whole bacterium or their shed
cell wall fragments by DC or receptor-mediated endocytosis (e.g., low-density lipoprotein receptor-medi-
ated) by DC and B cells. In the endolysosome, lipid transfer proteins such as saposins (Sap), GM2 activator
(GM2A), and Niemann-Pick type C2 protein facilitate glycolipid loading onto CD1d molecules, which then
egress to the cell surface for an appraisal by iNKT cells (Barral and Brenner, 2007). iNKT cells so activated
secrete IL-4, a T helper-2 differentiating and B cell growth factor, and IFN-g, a T helper-1 differentiating
and IgG2a class-switching factor. In N. aromaticivorans-infected mice, the generation of host mitochon-
drial pyruvate dehydrogenase complex (PDC)-E2-reactive IgG2a autoantibodies requires cognate iNKT-B
cell help and perhaps IFN-g. The observation that the adoptive transfer of iNKT cell-depleted, chronically
activated T cells from antibiotic-treated, N. aromaticivorans-infected mice into naive hosts also elicits
PDC-E2-reactive autoantibodies suggests that conventional T cells might also contribute to providing B
help (dashed two-way arrow). iNKT cell-activated B cells, because they express major histocompatibility
complex (MHC)-encoded class I and class II molecules, can activate conventional T cells (dashed
two-way arrow). Alternatively, DCs, which also express MHC class I and class II molecules, can activate
conventional T cells. Whether B cells (dashed two-way arrow), DC (dashed arrow), or both activate auto-
reactive T cells that precipitate PBC in the liver and which underlying mechanism(s) are involved remain
ill-defined.
(B) Liver inflammation in N. aromaticivorans-infected mice. Hematoxylin and eosin-stained section of the
liver showing portal inflammation (middle panel, 203) with bile duct damage (right panel, 1003) in a
7-month-oldmouse infectedwithN. aromaticivorans at 1month of age. Chronically activated conventional
T cells (red arrow) cause this inflammation. Whether autoantibodies (dashed red arrow) against mitochon-
drial PDC-E2 also participate in precipitating PBC remains unknown. The mouse liver histopathology
caused by N. aromaticivorans resembles human PBC. Photomicrographs reprinted with permission
(Mattner et al., 2008).276 Cell Host & Microbe 3, May 2008 ª2008 Elsevier Inc.This transactivation requires reciprocal
activation of dendritic cells (DC) and
iNKT cells (Vincent et al., 2002). Interleu-
kin (IL)-12 secreted by activated DC, cos-
timulatory CD40 ligand-CD40 interactions
between DC and autoreactive T cells, and
interferon (IFN)-g secreted by activated
iNKT cells likely play critical roles in the
initial activation and priming of autoanti-
gen-specific conventional T cells (Fig-
ure 1) (Fujii et al., 2004). B cells also pres-
ent MHC-restricted antigens to T cells.
Nevertheless, this interaction oftentimes
leads to T cell unresponsiveness. It is
therefore possible that the conventional
T-B cell interaction in the presence of
activated iNKT cells could lead to the
priming of autoreactive T cells (Figure 1).
Which of these events is operative in
PBC remains an open question. Indeed,
the finding that the transfer of activated
autoreactive T cells also promoted PDC-
E2-specific autoantibody production
(Mattner et al., 2008) indicates that con-
ventional T-B cell interaction might play
a role in PBC (Figure 1).
Mattner and coworkers’ findings raise
several questions of fundamental and
clinical import. First, which lymphoid
organ is critical for the initial activation of
iNKT cells by N. aromaticivorans? These
innate effector cells are enriched at
important immunological sites where
blood-borne pathogens enter peripheral
lymphoid organs. Because N. aromatici-
vorans infection causes hepatic hypertro-
phy and splenomegaly (Mattner et al.,
2008) and CD1d expression is enhanced
in the liver of individuals with PBC, the
whole bacterium or derived product(s)
could activate iNKT cells at both these
sites (Figure 1).
Second, iNKT cells have been impli-
cated in several immunopathologies. For
example, the plant lectin concanvalin A
causes liver injury in an iNKT cell-depen-
dent manner, and so does repeated
administration of aGalCer into mice and
humans (Van Kaer, 2005), expression
of a dominant-negative transforming b
receptor (Chuang et al., 2008), and T cell
lineage-specific expression of CD1d
(Zimmer et al., 2006). Whether these im-
munopathologies are similar to that pre-
cipitated by N. aromaticivorans remains
a mystery.
Third, iNKT cell activation promotes
inflammation in mouse models of ath-
erosclerosis and in some models of
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airway hyper-responsiveness (Van Kaer,
2005). Might microbial etiology, in the
context of iNKT cell activation, underlie
their immunopathologies as well? Last,
and most importantly, how do activated
iNKT cells facilitate breech of T and B
lymphocyte tolerance? Within answers
to these questions will lie therapeutic tar-
gets and countermeasures against debili-
tating chronic diseases of immunological
etiology. Hence, while the work of Mattner
and coworkers brings to focus significant
new insight into the innate immune mech-
anism underlying an autoimmune dis-
ease, much more remains to be learnt
about the physiologic and pathophysio-
logic roles of iNKT cells.CO-Opting the Ho
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Tuberculosis (TB) and malaria are two of
the world’s most important infectious dis-
eases; approximately 3.7 million deaths
per year and a staggering burden of mor-
bidity are attributable to these diseases
alone. Moreover, drug resistance has
made both infections more difficult to
treat, and neither is preventable with an
efficacious vaccine.
Two papers in this issue of Cell Host &
Microbe reveal a previously unknown
role for the host enzyme heme oxygenase
(HO) in these infections (Epiphanio et al.,
2008; Shiloh et al., 2008). HO catalyzes
degradation of heme to biliverdin, carbon
monoxide (CO), and free iron, and expres-
sion of HO-1, the inducible isoform of theACKNOWLEDGMENTS
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Malaria infection has two distinct
stages in the mammalian host: a clinically
silent pre-erythrocytic stage that is re-
quired for establishment of infection, and
an erythrocytic stage, responsible for all
of the clinical symptoms of malaria. Previ-
ously, Mota and her colleagues, using
a rodent model of malaria, showed that
HO-1 modulates the inflammatory re-
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and can protect mice from experimental
cerebral malaria (Pamplona et al., 2007).
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